As medical devices become smaller, more complex and subject to increasing regulatory scrutiny, choosing the right contract development and manufacturing organization (CDMO) has become a strategic decision. A manufacturing partner should do far more than produce parts—they should identify risks early, optimize manufacturability and help accelerate commercialization without compromising quality.

As companies seek to launch their medical devices in multiple regions globally, it’s important to understand the differing guidelines and regulations across geographies. But staying current on rules and regulations across areas can be challenging – especially when a company is considering its “first to launch” region.